financetom
Business
financetom
/
Business
/
National Bank Lodges Improved Q3 Earnings Driven By "Good Performance" Across Units, Moves to Complete CWB Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank Lodges Improved Q3 Earnings Driven By "Good Performance" Across Units, Moves to Complete CWB Acquisition
Aug 28, 2024 4:23 AM

06:58 AM EDT, 08/28/2024 (MT Newswires) -- National Bank (NA.TO) on Wednesday lodged improved earnings for the third quarter driven by "good performance" across its units as it moves to complete the acquisition of rival Canadian Western Bank ( CWESF ) .

National Bank reported adjusted net income, which excludes specified items -- notably the items related to the agreement to acquire CWB recorded during the third quarter of 2024 -- totalled $960 million compared to $781 million in the same quarter of 2023. Adjusted diluted earnings per share stood at $2.68 compared to $2.18 in the third quarter of 2023.

Net income came in at $1,033 million, up 24% from $830 million in the third quarter of 2023. Third-quarter diluted earnings per share stood at $2.89 compared to $2.33 in the third quarter of 2023. National Bank said these increases were driven by good performance in all of the business segments.

Capital IQ had different comparable estimates on earnings, and this likely reflects adjustments in the bank's results.

On the business segments, within Personal and Commercial, provisions for credit losses rose $4 million.

The bank will pay a dividend of $1.10 per common share for the quarter ending October 31, payable on November 1.

On Capital Management, as at July 31, the Common Equity Tier 1 capital ratio under Basel III stood at 13.5%, unchanged from October 31, 2023. As at July 31, 2024, the Basel III leverage ratio was 4.4%, unchanged from October 31, 2023.

On June 11, National Bank agreed to buy all of CWB's outstanding common shares by way of a share exchange valuing CWB at near $5 billion. National Bank said the transaction will enable it to "accelerate its growth" across Canada. The transaction is subject to the satisfaction of customary closing conditions, including regulatory approvals, and is expected to close in 2025.

"Our strong financial results for the third quarter reflect our diversified earnings mix and solid credit profile as well as disciplined execution across the Bank," said National Bank President and Chief Executive Laurent Ferreira. "With our prudent approach to capital, credit, and costs, we remain well-positioned in a complex macro environment and we look forward to the growth opportunities ahead."

National Bank saw its shares ease $0.74 to $119.89 on the TSX yesterday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US House panel subpoenas ESG corporate activist group
US House panel subpoenas ESG corporate activist group
Mar 22, 2024
WASHINGTON, March 21 (Reuters) - A U.S. House of Representatives panel has subpoenaed the head of an activist group that pressures companies over environmental, social and corporate governance issues to appear for a March 28 deposition, according to a letter seen by Reuters on Thursday. The Republican-led House Judiciary Committee is conducting a probe into whether ESG efforts violate antitrust...
Market Chatter: Apple Abandons Plan to Develop Its Own Displays for Smartwatch
Market Chatter: Apple Abandons Plan to Develop Its Own Displays for Smartwatch
Mar 22, 2024
02:45 PM EDT, 03/22/2024 (MT Newswires) -- Apple ( AAPL ) is no longer pursuing plans to build its own smartwatch displays due to the cost and complexity involved, Bloomberg reported Friday, citing people familiar with the matter. The microLED displays would have been introduced in a future version of the Apple Watch and were part of a push to...
US FDA grants full approval to AbbVie's ovarian cancer therapy
US FDA grants full approval to AbbVie's ovarian cancer therapy
Mar 22, 2024
March 22 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday it had granted traditional approval for AbbVie's ( ABBV ) guided missile cancer therapy, Elahere, for adult patients with a type of ovarian and related cancers who have received one to three prior lines of treatment. ...
CERAWEEK-Financiers grab reins as new energy startups struggle
CERAWEEK-Financiers grab reins as new energy startups struggle
Mar 22, 2024
HOUSTON, March 22 (Reuters) - Private equity firms are increasing their direct oversight of energy transition companies in their portfolios, taking on added duties to address runaway costs from supply chain issues and preserve valuations, executives said at the CERAWeek energy conference this week. Excitement around new energy technologies saw billions of dollars of investment poured in the last four...
Copyright 2023-2026 - www.financetom.com All Rights Reserved